14th International Conference on Malignant Lymphoma


14-17 June 2017, Lugano
Virtual Poster Gallery

Tel.: +34 91 736 2385
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:30, Fri 8:30-15:00
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
Captcha image


14th International Conference on Malignant Lymphoma


14-17 June 2017, Lugano
Most-visited poster
from congress
Volver a la portada del congreso

   140-169 | 170-195 | 196-221 | 222-247 | 252-285 | ...  Next range
posters found | 103
Poster no.
Poster/abstract title
Presentation date and time
P-252 Prognostic factors in patients with rela.. Yasuhiro Oki .. Tatyana Feldman, Dai Chihara, .. NK T-Cell Lymphomas.. - -
P-253 Case Match Control Analysis of PROPEL Re.. Owen OConnor .. .. NK T-Cell Lymphomas.. - -
P-254 A Post-marketing Surveillance Study of 7.. JUN MA .. .. NK T-Cell Lymphomas.. - -
P-255 Preliminary results from an open-label, .. Thomas Witzig .. Lubomir Sokol, Eric Jacobsen, .. NK T-Cell Lymphomas.. - -
P-256 Safety and efficacy of mogamulizumab in .. Kenji Ishitsuka .. .. NK T-Cell Lymphomas.. - -
P-257 Targeting the T-cell receptor -constant .. Paul Maciocia .. Wawrzyniecka P, Philip B, Aka.. NK T-Cell Lymphomas.. - -
P-258 Development of novel, non-toxic rifamyci.. Steve Maxwell .. .. New drug development.. - -
P-260 Dual inhibition of EZH2 and HDAC is syne.. Jennifer Lue .. Sathyen A. Prabhu MS, Yuxuan L.. New drug development.. - -
P-261 STRO-001, A NOVEL ANTI-CD74 ANTIBODY DRU.. Arturo Molina .. .. New drug development.. - -
P-263 Copanlisib in combination with anti-PD-1.. Ningshu Liu .. .. New drug development.. - -
P-264 PD--1 immune checkpoint blockade improve.. cedric rossi .. .. New drug development.. - -
P-265 Characterization and integration of mant.. David Chiron .. .. New drug development.. - -
P-266 Effective therapy by anti-CD81 against B.. Shoshana Levy .. Felipe Vences-Catalan, Chiung-.. New drug development.. - -
P-268 Expression of LAG-3 defines exhaustion o.. Zhizhang Yang .. .. New drug development.. - -
P-271 A phase I study of chimeric antigen rece.. Zhitao Ying .. .. New drug development.. - -
P-273 Safety and Clinical Activity of RP6530, .. Carmelo Carlo-Stella .. .. New drug development.. - -
P-278 Lenalidomide and Obinutuzumab with CHOP .. Jason Westin .. .. New drug development.. - -
P-280 The Immunologic Doublet of Lenalidomide .. Nathan Fowler .. .. New drug development.. - -
P-284 Polatuzumab vedotin plus bendamustine an.. Matthew Matasar .. Alex F. Herrera, Manali Kamdar.. New drug development.. - -
P-285 YourTreatmentChoices: Fast Access to Tri.. John Radford .. .. New drug development.. - -
Logo Cert
Close abstract


Thunderstorm-related asthma in patients sensitised to olea europaea pollen: twenty emergency department visits for asthmatic symptoms in one single day Losappio, Laura1; Heffler, Enrico2; Falco, Antonio1; Contento, Francesco1; Cannito, Cosimo1; Rolla, Giovanni2 1"Dimiccoli" Hospital, Emergency Department, Barletta, Italy; 2University of Torino - AO Mauriziano "Umberto I", Allergy and Clinical Immunology, Torino, Italy

Background: Associations between thunderstorm and asthma morbidity have been reported in several countries. Common to all epidemics of thunderstorm-related asthma is a significant increase in atmospheric allergen load during and immediately after a thunderstorm. Sensitization to Alternaria species or to grass and parietaria pollens has been suggested to play a key role in thunderstorm-related asthma. The only reported event of thunderstorm-related asthma in Mediterranean area was attributed to sensitization to parietaria pollen.

Method: here we describe a series of 20 patients who presented to Emergency Department in Barletta (94,000 inhabitants), Puglia (Italy) for sudden and severe asthmatic symptoms between May 27th and 28th 2010 (from15:36 to 5:02), immediately after a violent thunderstorm which occurred following a very hot morning (mean temperature: 29°C). All the patients have been subsequently visited by an allergist and underwent allergological work-up which included skin prick tests and a careful clinical history. Local pollen counts were available.

Result: Between May 10th and June 10th 2010, 86 Emergency Department asthma visits were recorded, 20 of them during the study day. Patients' mean age was 44.25 +/- 18.5 years (range: 9-81), 8/20 females, 2 smokers, 16 with a previous history of known respiratory allergy. Only two patients regularly took anti-asthma drugs. All 20 patients were sensitized to Olea europaea pollen, 7 of whom were monosensitized. Ten patients were sensitized to grass, 7 to parietaria, 5 to compositae, 5 to cypress, 5 to house dust mites, 3 to dog and 1 to cat danders. No patient was sensitized to Alternaria. Mean pollen count was 17 granules/m3 for Olea europaea, 6 granules/m3 for grass pollen.

Conclusion: This is, in our knowledge, the second epidemic of thunderstorm related asthma described in Mediterranean area and the first one in which sensitization to Olea europaea played a key-role. In conclusion, our report indicates that thunderstorm asthma may involve different allergens (not only fungal spores and grass or parietaria pollen) in different geographic areas, depending on the seasonality of thunderstorms and allergenic pollen.

Close poster